Details
Pathology is the cornerstone of toxicology studies—providing critical insights that influence decisions in drug and chemical development. From assessing microscopic tissue changes to interpreting complex histopathological findings, pathologists play a pivotal role in determining the safety and risk profile of test substances.
Join us for an in-depth session exploring the scientific and strategic role of pathologists in regulatory toxicology*, especially within the Indian preclinical research landscape.
*Offered through our partner laboratory, Adgyl Lifesciences.
What You’ll Learn:
- The vital role of pathologists in toxicology studies
- Training and expertise required for evaluating various animal models
- How pathology contributes to data interpretation and report value
- The pathologist’s role in guiding go/no-go decisions in product pipelines
- Insights into regulatory expectations and industry best practices
Whether you are a toxicologist, regulatory scientist, study director, or a researcher in preclinical development, this session will enrich your understanding of how pathology drives scientific integrity and regulatory confidence.
Speakers
Dr. Vijayasarathi K
Dr. Vijayasarathi K Consultant InvivoAdgyl Lifesciences Dr. Vijayasarathi is a highly respected pathologist with over 48 years of experience in academic and regulatory toxicology. He has authored 700+ GLP toxicology study reports, including 28+ carcinogenicity studies, and has been pivotal in histopathological evaluations across pharmaceuticals, agrochemicals, and biologics. He has mentored over 150 postgraduate students and published 95+ scientific papers. He is a Past President of STP-India, has held roles in global toxicologic pathology committees, and continues to be a sought-after expert in the field.